Searchable abstracts of presentations at key conferences in endocrinology

ea0099p271 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Obesity in transition towards diabesity: anthropometric determinants and markers of tissue damage

Mele Chiara , Mai Stefania , Borrini Martina , Cavigiolo Beatrice , Caputo Marina , Scacchi Massimo , Aimaretti Gianluca , Marzullo Paolo

Background: The term ‘Diabesity’ defines the complex relationship between obesity and type 2 diabetes mellitus (T2DM), that involves the convergent role of insulin resistance and chronic inflammation in amplifying the risk of systemic complications. To date, this link has not been fully characterized in terms of markers of tissue damage. The aim of this study was to investigate the association between the newly diagnosed glycemic alterations and the biomarkers of tis...

ea0099p485 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Diabetes mellitus in patients undergoing pancreatectomy (T3cDM): preliminary data analysis

Borrini Martina , Mele Chiara , Maroso Fabio , Pitino Rosa , Vimercati Davide , Romito Raffaele , Aimaretti Gianluca , Marzullo Paolo

Rationale and purpose: Glucose tolerance often changes in patients with pancreatic lesions and usually worsens after distal pancreatectomy; however, factors affecting interindividual variation in progression are unclear. Our study aimed to investigate the glyco-metabolic status in a series of patients undergoing pancreatic resection for treatment of benign or malignant lesions and risk factors involved in the developing T3cDM.Methods: We conducted an obs...

ea0081p474 | Thyroid | ECE2022

Potential risk factors for post-treatment recurrence in patients with intermediate-risk differentiated thyroid carcinoma

Rossi Mattia , Mele Chiara , Rossetto Giaccherino Ruth , Brero Denise , Marsan Giulia , Aimaretti Gianluca , Ghigo Ezio , Pagano Loredana

Introduction: The recurrence rate of intermediate-risk differentiated thyroid carcinoma (DTC) ranges between 5% and 20% and the therapeutic strategy requires further evaluations.Aim: We therefore investigated the potential risk factors for post-treatment recurrence of intermediate-risk DTC at 1 and 3 years from diagnosis.Methods: This retrospective observational study included 121 patients who underwent thyroidectomy for intermedia...

ea0056p616 | Neuroendocrinology | ECE2018

Use of a new classification algorithm based on administrative health databases to estimate incidence and prevalence of acromegaly in Piedmont Region, Italy

Caputo Marina , Ucciero Andrealuna , Mele Chiara , De Marchi Lucrezia , Magnani Corrado , Marzullo Paolo , Barone-Adesi Francesco , Aimaretti Gianluca

Background and aim: Information on incidence and prevalence of acromegaly usually originates from studies performed in referral endocrine care centers, whose catchment areas do not generally cover the entire population. Administrative databases can provide key information to assess the impact of acromegaly on patients and health systems. Our study aimed at estimating the prevalence and incidence data of acromegaly stratified by age and sex using data obtained in the Piedmont r...

ea0081p82 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Irisin in pediatric patients with Prader Willi Syndrome: the role of body composition and glucose metabolism

Mai Stefania , Fintini Danilo , Mele Chiara , Convertino Alessio , Bocchini Sarah , Grugni Graziano , Aimaretti Gianluca , Vietti Roberta , Scacchi Massimo , Crino Antonino , Marzullo Paolo

Irisin is a myokine involved in the browning of white adipose tissue and in the regulation of energy expenditure, glucose tolerance and insulin sensitivity. It was previously demonstrated that obese adults with Prader-Willi syndrome (PWS) harbor lower irisin levels than individuals with common obesity. Significant associations seem to relate irisin to muscle mass, REE, insulin resistance and triglycerides and also the strongest independent predictors of irisin levels were PWS ...

ea0081ep90 | Adrenal and Cardiovascular Endocrinology | ECE2022

Tumor enlargement in adrenal incidentaloma is related to glaucoma and statin treatment: are there two new prognostic features?

Ferrero Alice , Daffara Tommaso , Mele Chiara , Zavattaro Marco , Romanisio Martina , Cavigiolo Beatrice , Costelli Samuele , Caputo Marina , Marzullo Paolo , Prodam Flavia , Aimaretti Gianluca

Aim: The uncertainty on the management of small adrenal incidentalomas (AIs) in guidelines still represents a challenge in real clinical practice. The aim of the study was to identify risk factors for morphological or functional changes during follow-up by using clinical, radiological, and pathological features.Methods: We retrospectively evaluated demographic (gender and age at diagnosis), clinical (weight, height, body mass index, smoking habit, comorb...

ea0099rc4.1 | Rapid Communications 4: Diabetes, Obesity, Metabolism and Nutrition | Part I | ECE2024

Baseline hormonal profiling and post-surgical outcomes in patients with obesity undergoing bariatric surgery: Results from the novara experience

Mollero Edoardo Luigi Maria , Mele Chiara , Sama Maria Teresa , Prodam Flavia , Caputo Marina , Romanisio Martina , Cava Edda , Riso Sergio , Aimaretti Gianluca , Marzullo Paolo

Purpose: Obesity is a chronic disease with a high risk of cardiovascular and metabolic comorbidities, hence a decrease > 5-10% of the initial body weight (BW) is essential to achieve improvement of cardiometabolic dysfunction. Bariatric surgery currently represents a valid therapeutic option in this clinical setting, especially in patients unresponsive to a dietary-nutritional approach. Obesity instigates adaptive hormone changes, yet the role of baseline hormone setting o...